ISCA, CHRYSTEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.249
EU - Europa 2.002
AS - Asia 1.859
SA - Sud America 319
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 15
Totale 7.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.155
IT - Italia 731
SG - Singapore 489
CN - Cina 434
IE - Irlanda 254
GB - Regno Unito 240
BR - Brasile 221
VN - Vietnam 201
HK - Hong Kong 195
DE - Germania 173
SE - Svezia 153
BD - Bangladesh 149
FR - Francia 84
RU - Federazione Russa 76
IN - India 75
FI - Finlandia 71
KR - Corea 52
CA - Canada 51
ID - Indonesia 45
AR - Argentina 34
TR - Turchia 34
JP - Giappone 29
IQ - Iraq 27
EG - Egitto 26
LT - Lituania 26
NL - Olanda 26
MX - Messico 24
TW - Taiwan 23
UA - Ucraina 22
BG - Bulgaria 21
CO - Colombia 20
BE - Belgio 18
ES - Italia 18
MY - Malesia 18
PL - Polonia 18
PK - Pakistan 17
AU - Australia 15
CL - Cile 15
CZ - Repubblica Ceca 14
EC - Ecuador 12
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 10
AT - Austria 9
SA - Arabia Saudita 9
MD - Moldavia 8
MA - Marocco 7
VE - Venezuela 7
JO - Giordania 6
KE - Kenya 6
SY - Repubblica araba siriana 6
NP - Nepal 5
BH - Bahrain 4
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
GA - Gabon 2
GH - Ghana 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KH - Cambogia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
GT - Guatemala 1
HT - Haiti 1
IL - Israele 1
Totale 7.511
Salva come PNG Salva come JPEG
Città #
Ashburn 450
Santa Clara 322
Singapore 277
Chandler 255
Dublin 251
San Jose 195
Hong Kong 187
Fairfield 179
Dallas 139
Beijing 105
Nyköping 99
Hefei 98
New York 87
Council Bluffs 79
Houston 78
Southend 77
Los Angeles 72
London 71
Woodbridge 67
Helsinki 64
Ann Arbor 63
Milan 60
Seattle 59
Ho Chi Minh City 58
Modena 57
Wilmington 49
Cambridge 48
Seoul 47
Bologna 45
The Dalles 45
Hanoi 40
Dearborn 39
Chicago 34
Jakarta 31
Munich 31
Rome 31
Fremont 29
Lauterbourg 28
Frankfurt am Main 26
Redwood City 26
Shanghai 26
Moscow 23
San Diego 23
Orem 22
Tokyo 22
Sofia 21
São Paulo 21
Princeton 20
Toronto 20
Baghdad 19
Buffalo 19
Asyut 18
Bremen 16
Parma 16
Portsmouth 16
San Giuliano Milanese 15
Banqiao 14
Jacksonville 14
Mumbai 14
Phoenix 14
Reggio Emilia 14
Columbus 13
Des Moines 13
Warsaw 13
Brooklyn 12
Brussels 12
Da Nang 12
Dong Ket 12
Haiphong 12
Lawrence 12
Eugene 11
Madrid 11
Nuremberg 11
Poplar 11
Sassuolo 11
Denver 10
Izmir 10
Mexico City 10
Belo Horizonte 9
Brno 9
Castelvetrano 9
Düsseldorf 9
Guangzhou 9
Paris 9
Absecon 8
Atlanta 8
Bari 8
Cardiff 8
Chennai 8
Chisinau 8
Genoa 8
Manchester 8
Redondo Beach 8
Schiffdorf 8
Amsterdam 7
Melbourne 7
Montreal 7
Porto Alegre 7
Quito 7
Santorso 7
Totale 4.757
Salva come PNG Salva come JPEG
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 630
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 455
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 398
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 362
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 355
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 353
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 344
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 317
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 304
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 290
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 290
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 280
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 261
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 260
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 259
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 257
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 254
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 253
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 252
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 235
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 229
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 215
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 193
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 192
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 169
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 162
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer 11
Totale 7.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022526 57 41 33 28 20 46 20 24 47 53 95 62
2022/2023978 79 121 58 82 80 79 16 70 300 29 32 32
2023/2024605 28 25 51 65 59 75 76 57 33 30 53 53
2024/20251.493 45 18 36 104 273 202 129 111 166 103 118 188
2025/20262.873 198 79 270 256 376 163 358 149 241 284 237 262
2026/202789 89 0 0 0 0 0 0 0 0 0 0 0
Totale 7.580